Related Experiment Video
Updated: Mar 28, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone
Zaineb A F Albayati1, Manjula Sunkara2, Suzannah M Schmidt-Malan3
1College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Abstract:
We examined the pharmacokinetic properties of vancomycin conjugated to a bone-targeting agent (BT) with high affinity for hydroxyapatite after systemic intravenous administration. The results confirm enhanced persistence of BT-vancomycin in plasma and enhanced accumulation in bone relative to vancomycin. This suggests that BT-vancomycin may be a potential carrier for the systemic targeted delivery of vancomycin in the treatment of bone infections, potentially reducing the reliance on surgical debridement to achieve the desired therapeutic outcome.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Bone Remodeling
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibitors of Gram-positive Cell Wall Synthesis
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drugs that Destabilize Microtubules

